At a glance
Presentation: Injection · Up to 5 mL
Strength / amount: 10 mg
Price: From $172/month
Billing: Billed monthly. Cancel anytime.
PT-141 (bremelanotide) is a peptide that activates melanocortin receptors in the central nervous system, pathways involved in sexual desire and arousal. Unlike erectile dysfunction medications that work by increasing blood flow, PT-141 acts earlier, supporting the neurological signaling of desire. It is used by both men and women with low libido or difficulty with arousal. It is prepared by a state-licensed compounding pharmacy on a clinician's prescription.
What it can help with
- Sexual desire — may help support libido and sexual interest
- Arousal — may help support arousal and response
- As-needed use — taken ahead of anticipated sexual activity, not daily
- Complement — may be used alongside other approaches your clinician recommends
What to expect
PT-141 is used as needed, typically injected 30 to 60 minutes before sexual activity. Effects vary by person and by dose. Some respond after the first use; others see their response improve over a few uses as they adjust dose and timing with their clinician. Individual results vary and are not guaranteed.
How it works
How to use it: A small subcutaneous injection you give yourself 30 to 60 minutes before anticipated sexual activity, following your clinician's instructions. Your kit includes everything you need: vials, syringes, and a step-by-step guide.
How to start: Place your order and complete a brief online medical intake. A licensed clinician reviews your history to determine whether the treatment is appropriate for you. In some states a short telehealth appointment may be required (at no additional cost) before a prescription is issued. If approved, your treatment is prepared by a state-licensed pharmacy and shipped discreetly to your door. Most clients receive their first order within a week.
After your first delivery, a new supply arrives automatically every 4 weeks — no reordering needed. You can delay a shipment or cancel anytime from your account.
Your dose: Personalized by your clinician and adjusted over time based on how your body responds to treatment and how your health needs change.
Important to know
- PT-141 is a prescription medication and requires evaluation by a licensed clinician.
- The FDA-approved version of bremelanotide (Vyleesi) is approved for hypoactive sexual desire disorder in premenopausal women. PT-141 is prescribed off-label for other patients and uses.
- This medication is compounded and is not FDA-approved as a finished product.
- PT-141 is not appropriate for people with uncontrolled high blood pressure or cardiovascular disease. Individual results vary and are not guaranteed.
Prescription treatment. Eligibility, dose, contraindications, monitoring, and follow-up are determined by the licensed clinician. Product availability and fulfillment may vary.
